Funder directory / Canada / Venture capital firms

Lumira Ventures

Venture capitalToronto, Canadalumiraventures.comVerified 9 Nov 2026

Lumira Ventures is a North American life sciences venture capital firm headquartered in Toronto. It invests in biotherapeutic and medical device companies developing transformative products for patients across various stages of development.

StagesSeries A · Series B+

Invests inCA · US

Deals recorded40 since 2002

What they invest in

Health

We partner with mission-driven entrepreneurs to build transformative life sciences companies focused on developing and commercializing impactful products for patients source
We are proud to help top-tier biotherapeutic and medical device companies realize their vision. source

All investments and operations

40 operations

Company	Round	Amount	Date	Co-investors	Source
Depomed Biopharmaceutical, US	PIPE	–	2003	–	Portfolio page
ISTA Pharmaceuticals Biopharmaceutical, US	–	–	2002	–	Portfolio page
Alpha-9 Biotechnology	–	–	–	–	Portfolio page
Altis Labs Tools & Diagnostics, CA	Series A	–	–	–	Portfolio page
Alveolus Biotechnology, US	–	–	–	–	Portfolio page
AmacaThera Biopharmaceutical, CA	–	–	–	–	Portfolio page
Antiva Biosciences Biopharmaceutical, US	–	–	–	–	Portfolio page
Arclight Therapeutics Biopharmaceutical, US	–	–	–	–	Portfolio page
Aurinia Pharmaceuticals Biotechnology, CA	–	–	–	–	Portfolio page
Axonis Biopharmaceutical, US	–	–	–	–	Portfolio page

Show all 40 operations

Bardy Medical Device, US	–	–	–	–	Portfolio page
BioTheryX Biopharmaceutical, US	–	–	–	–	Portfolio page
Cadence Neuroscience Medical Device	–	–	–	–	Portfolio page
Ception Therapeutics Biopharmaceutical, US	–	–	–	–	Portfolio page
Contraline	Series B	–	–	–	Portfolio page
Corus Pharmaceuticals Biopharmaceutical, US	–	–	–	–	Portfolio page
COUR Pharma	Series B	–	–	–	Portfolio page
Cyrano Therapeutics	–	–	–	–	Portfolio page
Edesa Biotech Biopharmaceutical, CA	–	–	–	–	Portfolio page
Endotronix Medical Device, US	–	–	–	–	Portfolio page
Engage Therapeutics Biopharmaceutical, US	–	–	–	–	Portfolio page
ESSA Pharmaceuticals Biotechnology, CA	–	–	–	–	Portfolio page
Forbius Biopharmaceutical, CA	–	–	–	–	Portfolio page
Fusion Pharmaceuticals Biopharmaceutical, CA	–	–	–	–	Portfolio page
G1 Therapeutics Biopharmaceutical, US	–	–	–	–	Portfolio page
Guava Technologies Biopharmaceutical, US	–	–	–	–	Portfolio page
HistoSonics	–	–	–	–	Portfolio page
KAI Pharmaceuticals Biopharmaceutical, US	–	–	–	–	Portfolio page
MAKO Surgical Medical Device, US	–	–	–	–	Portfolio page
Morphotek Biopharmaceutical, US	–	–	–	–	Portfolio page
Nervonik	Series B	–	–	–	Portfolio page
OpSens Medical Medical Device, CA	–	–	–	–	Portfolio page
Pharmasset Biopharmaceutical, US	–	–	–	–	Portfolio page
Resonant Medical Medical Device, CA	–	–	–	–	Portfolio page
Sound Blade Medical	–	–	–	–	Portfolio page
Specific Biologics	Series A	–	–	–	Portfolio page
Spinal Kinetics Medical Device, US	–	–	–	–	Portfolio page
Think Research Biopharmaceutical, CA	–	–	–	–	Portfolio page
U-Systems Medical Device, US	–	–	–	–	Portfolio page
Zymeworks Biotechnology, CA	–	–	–	–	Portfolio page

Exits

OpSens Medical Acquired by Haemonetics2023 · Source
Bardy Acquired by Hillrom2021 · Source
Forbius Acquired by Bristol Myers Squibb2020 · Source
Engage Therapeutics Acquired by UBC2020 · Source
Spinal Kinetics Acquired by Orthofix2018 · Source
MAKO Surgical Acquired by Stryker2013 · Source
U-Systems Acquired by GE Healthcare Limited2012 · Source
KAI Pharmaceuticals Acquired by Amgen2012 · Source
Pharmasset Acquired by Gilead2011 · Source
Ception Therapeutics Acquired by Cephalon Inc.2010 · Source

Shown only when an exit is documented by a public source.

Reports and papers

Canadian Venture Capital Market Overview Q1 2025
Mentions this funder · CVCA · January 2025 · 32 pages

Similar funders

Accelerate Fund · Venture capital, Canada
AmorChem · Venture capital, Canada
Amplify Capital · Venture capital, Canada
Amplitude Ventures · Venture capital, Canada
Archangel Network of Funds · Venture capital, Canada
Beedie Capital · Venture capital, Canada